Raffa Wealth Management’s Krystal Biotech KRYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$665 Hold
2
– – ﹤0.01% 1129
2026
Q2
$743 Buy
+2
New +$598 ﹤0.01% 1107

Other funds holding KRYS

Raffa Wealth Management's KRYS Position: Q3 2026 in Review

Raffa Wealth Management held its Krystal Biotech (KRYS) position steady in Q3 2026 at 2 shares worth $665. The position accounts for ﹤0.01% of the portfolio, ranked #1129.

Raffa Wealth Management first reported a position in KRYS in Q2 2026 and has held it in 2 quarters since. The position peaked at $743 in Q2 2026. 442 funds tracked by Wall St. Rank hold KRYS as of Q3 2026.

  • Raffa Wealth Management held 2 shares of Krystal Biotech worth $665 as of Q3 2026.
  • Raffa Wealth Management left its Krystal Biotech share count unchanged in Q3 2026.
  • Krystal Biotech made up ﹤0.01% of Raffa Wealth Management's portfolio in Q3 2026, its #1129 holding.
  • Raffa Wealth Management first reported a position in Krystal Biotech in Q2 2026 and has held it in 2 quarters since.
  • Raffa Wealth Management's Krystal Biotech position peaked at $743 in Q2 2026.
  • 442 funds tracked by Wall St. Rank held Krystal Biotech as of Q3 2026.

Based on Raffa Wealth Management's 13F filing for Q3 2026, filed 16 Nov 2026.